SCHEMBL6983136

SCHEMBL6983136

CSc1ccc2c(c1)NS(=O)(=O)N(C(C)C)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
HTR2B P41595 1/20 0.36
KDM4E B2RXH2 1/20 0.35
RECQL P46063 1/20 0.35
MAPT P10636 2/20 0.30
HTR7 P34969 2/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HTR1A P08908 1/20 0.30
MTOR P42345 1/20 0.30
HTT P42858 1/20 0.30
HTR5A P47898 1/20 0.30
HTR6 P50406 1/20 0.30
RAB9A P51151 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6490844 0.89 KDM4E (0.35) HTR2AHTR2CHTR2BKDM4ERECQL
SCHEMBL8316408 0.80 DPP8 (0.36) KDM4ERECQL
SCHEMBL2603740 0.77 KDM4E (0.47) KDM4ERECQL
SCHEMBL6975709 0.77 PNMT (0.38)
SCHEMBL8318662 0.71 DPP8 (0.36) KDM4ERECQL
SCHEMBL8317800 0.69 RYR2 (0.42) KDM4EMAPTALDH1A1
SCHEMBL6490566 0.69 PNMT (0.38) KDM4ERECQLHTR6
SCHEMBL6978812 0.69 MAPT (0.40) KDM4ERECQLMAPTNPC1ALDH1A1
SCHEMBL6985370 0.69 NAMPT (0.32) KDM4ERECQLMAPTRAB9A
SCHEMBL6984360 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131321-B1 INDOLE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR LIGANDS LILLY CO ELI (GB) 2003-09-10 EP disclosed
US-6329366-B1 HETEROCYCLIC, PIPERIDINE, INDOLE DERIVITIVES FOR TREATMENT OF NERVOUS SYSTEM DISORDERS AND SEROTONIN ANTAGONIST ELI LILLY AND COMPANY LIMITED (GB) 2001-12-11 US disclosed